The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2025
Filed:
Mar. 14, 2024
Applicant:
Medimmune Limited, Cambridge, GB;
Inventors:
Maria Groves, Cambridge, GB;
Suzanne Gustavsson, Huddinge, SE;
Kina Höglund, Solna, SE;
Chris Lloyd, Cambridge, GB;
Adrian Nickson, Cambridge, GB;
Camilla Niva, Arsta, SE;
Sylvia Simon, Stockholm, SE;
David Lowne, Cambridge, GB;
Fraser Welsh, Cambridge, GB;
Per-Ola Freskgärd, Södertälje, SE;
Assignee:
MedImmune Limited, Cambridge, GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61P 25/28 (2018.01); A61K 38/1716 (2013.01); A61K 39/3955 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/33 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/60 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01);
Abstract
Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.